Showing results (5121-5130 of 9,342) with videos related to
Sort By:
Pageof 935
Cancer Medicine|August 17, 2023
The effects of tislelizumab treatment on the health-related quality of life of patients with advanced non-small cell lung cancerDingzhi Huang, Caicun Zhou, Gisoo Barnes, et al.Cancer Medicine|August 23, 2023
Personalising monitoring for chemotherapy patients through predicting deterioration in renal and hepatic functionPinkie Chambers, Matthew Watson, John Bridgewater, et al.Cancer Medicine|August 23, 2023
Prevalence and spectrum of cancer predisposition germline mutations in young patients with the common late-onset cancersShaoyu Hao, Ximeng Zhao, Yue Fan, et al.Cancer Medicine|July 31, 2023
Growth of community-based immunotherapy treatment in the Veterans Health AdministrationMegan Ellis Price, Sarah Gordon, Caroline Emmitt, et al.Cancer Medicine|August 1, 2023
Blood and saliva-derived ctDNA is a marker of residual disease after treatment and correlates with recurrence in human papillomavirus-associated head and neck cancerSarah Tadhg Ferrier, Thupten Tsering, Nader Sadeghi, et al.Cancer Medicine|July 31, 2023
The impact of COVID-19 on mortality, length of stay, and cost of care among patients with gastrointestinal malignancies: A propensity score-matched analysisMark B Ulanja, Bryce D Beutler, Kwabena Oppong Asafo-Agyei, et al.Cancer Medicine|July 31, 2023
Efficacy of chemotherapy combined with surgical resection for gastric cancer with synchronous ovarian metastasis: A propensity score matching analysisJingquan Fang, Xingmao Huang, Xiangliu Chen, et al.Cancer Medicine|October 16, 2023
MRI-based radiomic signatures for pretreatment prognostication in cervical cancerKari S Wagner-Larsen, Erlend Hodneland, Kristine E Fasmer, et al.Cancer Medicine|October 11, 2023
Selinexor for the treatment of recurrent or metastatic salivary gland tumors: Results from the GEMS-001 clinical trialAlberto Hernando-Calvo, Eoghan Malone, Daphne Day, et al.Cancer Medicine|October 9, 2023
Risk factors for overweight and obesity after childhood acute lymphoblastic leukemia in North America and Switzerland: A comparison of two cohort studiesFabiën N Belle, Christina Schindera, Marc Ansari, et al.Pageof 935